COVID-19 is an emerging, rapidly evolving situation.

University of North Carolina at Chapel Hill (previously funded)

When this Center’s funding ended in 2013, researchers were developing and testing cell- and gene-based approaches to correct the molecular defects underlying Duchenne muscular dystrophy.

Partner institution: University of Wisconsin-Madison